Arno Therapeutics to Present Data on Two Potential Predictive Biomarkers at SABCS 2013

Arno Therapeutics (OTC: ARNI ) today announced that data from a biomarker study supporting its lead compound onapristone will be presented at a poster session at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) annual meeting, being held December 10-14, 2013 in San Antonio, Texas. The symposium is